Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy

Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the four...

Full description

Saved in:
Bibliographic Details
Published in:Human vaccines & immunotherapeutics 2022-11, Vol.18 (6), p.2141998-2141998
Main Authors: Costantino, Claudio, Cimino, Livia, Bonaccorso, Nicole, Conforto, Arianna, Sciortino, Martina, Blangiardi, Francesco, Bosco, Girolama, Canzoneri, Gaspare, Casuccio, Nicolò, Collura, Calogero, Cuccia, Mario, Furnari, Roberto, Genovese, Pietro, Gucciardi, Giovanni, Randazzo, Maria Angela, Taranto, Gino Enzo, Palermo, Mario, Vitale, Francesco
Format: Article
Language:English
Subjects:
Child
co-administration
Diphtheria-Tetanus-Pertussis Vaccine
Haemophilus Vaccines
Hepatitis B Vaccines
Hexavalent vaccine
Humans
Immunization Schedule
Infant
Infant, Newborn
interchangeability
Licensed Vaccines
Poliovirus Vaccine, Inactivated
Public Health
real-life vaccination
Retrospective Studies
Sicily
Vaccination - methods
vaccination coverage
Vaccines, Combined
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203
cites cdi_FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203
container_end_page 2141998
container_issue 6
container_start_page 2141998
container_title Human vaccines & immunotherapeutics
container_volume 18
creator Costantino, Claudio
Cimino, Livia
Bonaccorso, Nicole
Conforto, Arianna
Sciortino, Martina
Blangiardi, Francesco
Bosco, Girolama
Canzoneri, Gaspare
Casuccio, Nicolò
Collura, Calogero
Cuccia, Mario
Furnari, Roberto
Genovese, Pietro
Gucciardi, Giovanni
Randazzo, Maria Angela
Taranto, Gino Enzo
Palermo, Mario
Vitale, Francesco
description Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016-2017 (DTaP3-IPV-HB/Hib) and 2018-2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of administration was significantly higher in children who switched between the two hexavalent vaccines compared to those who completed the vaccination cycle with the same product (p-value 36 months) significantly after the introduction of mandatory vaccination in Italy (p-value
doi_str_mv 10.1080/21645515.2022.2141998
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_33eab6fd4a744261ace023847fcc1f0a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_33eab6fd4a744261ace023847fcc1f0a</doaj_id><sourcerecordid>2732538541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203</originalsourceid><addsrcrecordid>eNp9kttuEzEQhlcIRKvSRwD5skgk-Ly7XCBQRSFSJSQOEnfWxOtJXHnXwd4E8kp9yjpNGtEbfDP2-J9vRvZfVS8ZnTLa0LecaakUU1NOOZ9yJlnbNk-q011-opT89fS4Z-qkOs_5hpZVUy61fl6dCC0EVY08rW6_OQgkeHRk6f7CBoIbRrIBa_0Ao48DgT4OC2KXPnTJlWMmQFYJ7OhtqVysfecIxkRW63nwtlAgjMuiiOhyLgAI-R25iutEtg5SJheYYk84ZZqMcRfb1yQiscEP98QD2xE_kO_e-rB9Q2YjhO2L6hkWmDs_xLPq59WnH5dfJtdfP88uP15PrBJynHQdCod83qCrWz23tOEAtLFSATSIbUdrkKphiLWs9VyKDpjGVgjUjCGn4qya7bldhBuzSr6HtDURvLlPxLQwkMqEwRkhHMw1dhJqKblmYB3lopE1WsuQQmG937PK6_Sus-VxE4RH0Mc3g1-aRdyYtpZaKFUAFwdAir_XLo-m99m6EGBwcZ0NrwVXolGSFanaS22KOSeHxzaMmp1tzINtzM425mCbUvfq3xmPVQ8mKYIPe4Efykf38Cem0JkRtiEmTDBYn434f487xi_TyA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2732538541</pqid></control><display><type>article</type><title>Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy</title><source>Taylor &amp; Francis Open Access</source><source>PubMed Central</source><creator>Costantino, Claudio ; Cimino, Livia ; Bonaccorso, Nicole ; Conforto, Arianna ; Sciortino, Martina ; Blangiardi, Francesco ; Bosco, Girolama ; Canzoneri, Gaspare ; Casuccio, Nicolò ; Collura, Calogero ; Cuccia, Mario ; Furnari, Roberto ; Genovese, Pietro ; Gucciardi, Giovanni ; Randazzo, Maria Angela ; Taranto, Gino Enzo ; Palermo, Mario ; Vitale, Francesco</creator><creatorcontrib>Costantino, Claudio ; Cimino, Livia ; Bonaccorso, Nicole ; Conforto, Arianna ; Sciortino, Martina ; Blangiardi, Francesco ; Bosco, Girolama ; Canzoneri, Gaspare ; Casuccio, Nicolò ; Collura, Calogero ; Cuccia, Mario ; Furnari, Roberto ; Genovese, Pietro ; Gucciardi, Giovanni ; Randazzo, Maria Angela ; Taranto, Gino Enzo ; Palermo, Mario ; Vitale, Francesco</creatorcontrib><description>Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016-2017 (DTaP3-IPV-HB/Hib) and 2018-2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of administration was significantly higher in children who switched between the two hexavalent vaccines compared to those who completed the vaccination cycle with the same product (p-value &lt;.01). Interchangeability with one or two doses of HV was also documented in 17.8% (2018) and 16% (2019) of vaccinated infants. Co-administration with other vaccines included in the Sicilian Vaccination Schedule was 85% with anti-pneumococcal vaccination and 65% with anti-rotavirus vaccination. Children vaccinated above recommended age (from 15 to &gt;36 months) significantly after the introduction of mandatory vaccination in Italy (p-value &lt;.001). This retrospective analysis will contribute to manage potential disruptions due to missed routine immunization opportunities, as the pandemic has caused, with strategies such as catch up above recommended age as well as interchangeability. Data could also help to demonstrate the need to optimize vaccine sessions through co-administration, that strongly contribute to increase vaccination coverage rates and respect of timing of vaccination schedules.</description><identifier>ISSN: 2164-5515</identifier><identifier>EISSN: 2164-554X</identifier><identifier>DOI: 10.1080/21645515.2022.2141998</identifier><identifier>PMID: 36330584</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Child ; co-administration ; Diphtheria-Tetanus-Pertussis Vaccine ; Haemophilus Vaccines ; Hepatitis B Vaccines ; Hexavalent vaccine ; Humans ; Immunization Schedule ; Infant ; Infant, Newborn ; interchangeability ; Licensed Vaccines ; Poliovirus Vaccine, Inactivated ; Public Health ; real-life vaccination ; Retrospective Studies ; Sicily ; Vaccination - methods ; vaccination coverage ; Vaccines, Combined</subject><ispartof>Human vaccines &amp; immunotherapeutics, 2022-11, Vol.18 (6), p.2141998-2141998</ispartof><rights>2022 The Author(s). Published with license by Taylor &amp; Francis Group, LLC. 2022</rights><rights>2022 The Author(s). Published with license by Taylor &amp; Francis Group, LLC. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203</citedby><cites>FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203</cites><orcidid>0000-0002-8021-8151 ; 0000-0002-3397-7331</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746355/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746355/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36330584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Costantino, Claudio</creatorcontrib><creatorcontrib>Cimino, Livia</creatorcontrib><creatorcontrib>Bonaccorso, Nicole</creatorcontrib><creatorcontrib>Conforto, Arianna</creatorcontrib><creatorcontrib>Sciortino, Martina</creatorcontrib><creatorcontrib>Blangiardi, Francesco</creatorcontrib><creatorcontrib>Bosco, Girolama</creatorcontrib><creatorcontrib>Canzoneri, Gaspare</creatorcontrib><creatorcontrib>Casuccio, Nicolò</creatorcontrib><creatorcontrib>Collura, Calogero</creatorcontrib><creatorcontrib>Cuccia, Mario</creatorcontrib><creatorcontrib>Furnari, Roberto</creatorcontrib><creatorcontrib>Genovese, Pietro</creatorcontrib><creatorcontrib>Gucciardi, Giovanni</creatorcontrib><creatorcontrib>Randazzo, Maria Angela</creatorcontrib><creatorcontrib>Taranto, Gino Enzo</creatorcontrib><creatorcontrib>Palermo, Mario</creatorcontrib><creatorcontrib>Vitale, Francesco</creatorcontrib><title>Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy</title><title>Human vaccines &amp; immunotherapeutics</title><addtitle>Hum Vaccin Immunother</addtitle><description>Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016-2017 (DTaP3-IPV-HB/Hib) and 2018-2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of administration was significantly higher in children who switched between the two hexavalent vaccines compared to those who completed the vaccination cycle with the same product (p-value &lt;.01). Interchangeability with one or two doses of HV was also documented in 17.8% (2018) and 16% (2019) of vaccinated infants. Co-administration with other vaccines included in the Sicilian Vaccination Schedule was 85% with anti-pneumococcal vaccination and 65% with anti-rotavirus vaccination. Children vaccinated above recommended age (from 15 to &gt;36 months) significantly after the introduction of mandatory vaccination in Italy (p-value &lt;.001). This retrospective analysis will contribute to manage potential disruptions due to missed routine immunization opportunities, as the pandemic has caused, with strategies such as catch up above recommended age as well as interchangeability. Data could also help to demonstrate the need to optimize vaccine sessions through co-administration, that strongly contribute to increase vaccination coverage rates and respect of timing of vaccination schedules.</description><subject>Child</subject><subject>co-administration</subject><subject>Diphtheria-Tetanus-Pertussis Vaccine</subject><subject>Haemophilus Vaccines</subject><subject>Hepatitis B Vaccines</subject><subject>Hexavalent vaccine</subject><subject>Humans</subject><subject>Immunization Schedule</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>interchangeability</subject><subject>Licensed Vaccines</subject><subject>Poliovirus Vaccine, Inactivated</subject><subject>Public Health</subject><subject>real-life vaccination</subject><subject>Retrospective Studies</subject><subject>Sicily</subject><subject>Vaccination - methods</subject><subject>vaccination coverage</subject><subject>Vaccines, Combined</subject><issn>2164-5515</issn><issn>2164-554X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>DOA</sourceid><recordid>eNp9kttuEzEQhlcIRKvSRwD5skgk-Ly7XCBQRSFSJSQOEnfWxOtJXHnXwd4E8kp9yjpNGtEbfDP2-J9vRvZfVS8ZnTLa0LecaakUU1NOOZ9yJlnbNk-q011-opT89fS4Z-qkOs_5hpZVUy61fl6dCC0EVY08rW6_OQgkeHRk6f7CBoIbRrIBa_0Ao48DgT4OC2KXPnTJlWMmQFYJ7OhtqVysfecIxkRW63nwtlAgjMuiiOhyLgAI-R25iutEtg5SJheYYk84ZZqMcRfb1yQiscEP98QD2xE_kO_e-rB9Q2YjhO2L6hkWmDs_xLPq59WnH5dfJtdfP88uP15PrBJynHQdCod83qCrWz23tOEAtLFSATSIbUdrkKphiLWs9VyKDpjGVgjUjCGn4qya7bldhBuzSr6HtDURvLlPxLQwkMqEwRkhHMw1dhJqKblmYB3lopE1WsuQQmG937PK6_Sus-VxE4RH0Mc3g1-aRdyYtpZaKFUAFwdAir_XLo-m99m6EGBwcZ0NrwVXolGSFanaS22KOSeHxzaMmp1tzINtzM425mCbUvfq3xmPVQ8mKYIPe4Efykf38Cem0JkRtiEmTDBYn434f487xi_TyA</recordid><startdate>20221130</startdate><enddate>20221130</enddate><creator>Costantino, Claudio</creator><creator>Cimino, Livia</creator><creator>Bonaccorso, Nicole</creator><creator>Conforto, Arianna</creator><creator>Sciortino, Martina</creator><creator>Blangiardi, Francesco</creator><creator>Bosco, Girolama</creator><creator>Canzoneri, Gaspare</creator><creator>Casuccio, Nicolò</creator><creator>Collura, Calogero</creator><creator>Cuccia, Mario</creator><creator>Furnari, Roberto</creator><creator>Genovese, Pietro</creator><creator>Gucciardi, Giovanni</creator><creator>Randazzo, Maria Angela</creator><creator>Taranto, Gino Enzo</creator><creator>Palermo, Mario</creator><creator>Vitale, Francesco</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8021-8151</orcidid><orcidid>https://orcid.org/0000-0002-3397-7331</orcidid></search><sort><creationdate>20221130</creationdate><title>Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy</title><author>Costantino, Claudio ; Cimino, Livia ; Bonaccorso, Nicole ; Conforto, Arianna ; Sciortino, Martina ; Blangiardi, Francesco ; Bosco, Girolama ; Canzoneri, Gaspare ; Casuccio, Nicolò ; Collura, Calogero ; Cuccia, Mario ; Furnari, Roberto ; Genovese, Pietro ; Gucciardi, Giovanni ; Randazzo, Maria Angela ; Taranto, Gino Enzo ; Palermo, Mario ; Vitale, Francesco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Child</topic><topic>co-administration</topic><topic>Diphtheria-Tetanus-Pertussis Vaccine</topic><topic>Haemophilus Vaccines</topic><topic>Hepatitis B Vaccines</topic><topic>Hexavalent vaccine</topic><topic>Humans</topic><topic>Immunization Schedule</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>interchangeability</topic><topic>Licensed Vaccines</topic><topic>Poliovirus Vaccine, Inactivated</topic><topic>Public Health</topic><topic>real-life vaccination</topic><topic>Retrospective Studies</topic><topic>Sicily</topic><topic>Vaccination - methods</topic><topic>vaccination coverage</topic><topic>Vaccines, Combined</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Costantino, Claudio</creatorcontrib><creatorcontrib>Cimino, Livia</creatorcontrib><creatorcontrib>Bonaccorso, Nicole</creatorcontrib><creatorcontrib>Conforto, Arianna</creatorcontrib><creatorcontrib>Sciortino, Martina</creatorcontrib><creatorcontrib>Blangiardi, Francesco</creatorcontrib><creatorcontrib>Bosco, Girolama</creatorcontrib><creatorcontrib>Canzoneri, Gaspare</creatorcontrib><creatorcontrib>Casuccio, Nicolò</creatorcontrib><creatorcontrib>Collura, Calogero</creatorcontrib><creatorcontrib>Cuccia, Mario</creatorcontrib><creatorcontrib>Furnari, Roberto</creatorcontrib><creatorcontrib>Genovese, Pietro</creatorcontrib><creatorcontrib>Gucciardi, Giovanni</creatorcontrib><creatorcontrib>Randazzo, Maria Angela</creatorcontrib><creatorcontrib>Taranto, Gino Enzo</creatorcontrib><creatorcontrib>Palermo, Mario</creatorcontrib><creatorcontrib>Vitale, Francesco</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Human vaccines &amp; immunotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Costantino, Claudio</au><au>Cimino, Livia</au><au>Bonaccorso, Nicole</au><au>Conforto, Arianna</au><au>Sciortino, Martina</au><au>Blangiardi, Francesco</au><au>Bosco, Girolama</au><au>Canzoneri, Gaspare</au><au>Casuccio, Nicolò</au><au>Collura, Calogero</au><au>Cuccia, Mario</au><au>Furnari, Roberto</au><au>Genovese, Pietro</au><au>Gucciardi, Giovanni</au><au>Randazzo, Maria Angela</au><au>Taranto, Gino Enzo</au><au>Palermo, Mario</au><au>Vitale, Francesco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy</atitle><jtitle>Human vaccines &amp; immunotherapeutics</jtitle><addtitle>Hum Vaccin Immunother</addtitle><date>2022-11-30</date><risdate>2022</risdate><volume>18</volume><issue>6</issue><spage>2141998</spage><epage>2141998</epage><pages>2141998-2141998</pages><issn>2164-5515</issn><eissn>2164-554X</eissn><abstract>Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016-2017 (DTaP3-IPV-HB/Hib) and 2018-2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of administration was significantly higher in children who switched between the two hexavalent vaccines compared to those who completed the vaccination cycle with the same product (p-value &lt;.01). Interchangeability with one or two doses of HV was also documented in 17.8% (2018) and 16% (2019) of vaccinated infants. Co-administration with other vaccines included in the Sicilian Vaccination Schedule was 85% with anti-pneumococcal vaccination and 65% with anti-rotavirus vaccination. Children vaccinated above recommended age (from 15 to &gt;36 months) significantly after the introduction of mandatory vaccination in Italy (p-value &lt;.001). This retrospective analysis will contribute to manage potential disruptions due to missed routine immunization opportunities, as the pandemic has caused, with strategies such as catch up above recommended age as well as interchangeability. Data could also help to demonstrate the need to optimize vaccine sessions through co-administration, that strongly contribute to increase vaccination coverage rates and respect of timing of vaccination schedules.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>36330584</pmid><doi>10.1080/21645515.2022.2141998</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8021-8151</orcidid><orcidid>https://orcid.org/0000-0002-3397-7331</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2164-5515
ispartof Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2141998-2141998
issn 2164-5515
2164-554X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_33eab6fd4a744261ace023847fcc1f0a
source Taylor & Francis Open Access; PubMed Central
subjects Child
co-administration
Diphtheria-Tetanus-Pertussis Vaccine
Haemophilus Vaccines
Hepatitis B Vaccines
Hexavalent vaccine
Humans
Immunization Schedule
Infant
Infant, Newborn
interchangeability
Licensed Vaccines
Poliovirus Vaccine, Inactivated
Public Health
real-life vaccination
Retrospective Studies
Sicily
Vaccination - methods
vaccination coverage
Vaccines, Combined
title Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical practice in Sicily, Italy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A40%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real%20life%20hexavalent%20vaccination%20among%20children%20as%20a%20practical%20guide%20for%20public%20health%20professionals:%20Four%20years%20(from%202016%20to%202019)%20of%20clinical%20practice%20in%20Sicily,%20Italy&rft.jtitle=Human%20vaccines%20&%20immunotherapeutics&rft.au=Costantino,%20Claudio&rft.date=2022-11-30&rft.volume=18&rft.issue=6&rft.spage=2141998&rft.epage=2141998&rft.pages=2141998-2141998&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.1080/21645515.2022.2141998&rft_dat=%3Cproquest_doaj_%3E2732538541%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-ddf3ef2b8fe796bc082aa08c45aa8ff9d07a4581ff7476b43da16f933f611f203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2732538541&rft_id=info:pmid/36330584&rfr_iscdi=true